BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/25/2023 8:49:11 AM | Browse: 403 | Download: 1315
 |
Received |
|
2023-07-27 03:32 |
|
Peer-Review Started |
|
2023-07-27 03:36 |
|
First Decision by Editorial Office Director |
|
2023-09-26 09:34 |
|
Return for Revision |
|
2023-09-26 09:34 |
|
Revised |
|
2023-09-26 15:03 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-10-07 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-10-08 03:58 |
|
Articles in Press |
|
2023-10-08 03:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-10-13 02:14 |
|
Publish the Manuscript Online |
|
2023-10-25 08:49 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shih-Chung Lai, El-Wui Loh, Du-I Chiou and Chien-Tai Hong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chien-Tai Hong, MD, PhD, Associate Professor, Department of Neurology, Taipei Medical University-Shuang Ho Hospital, Taipei 110, Taiwan. ct.hong@tmu.edu.tw |
| Key Words |
Efficacy; Safety; Anti-vascular endothelial growth factor agents; Corneal neovascularization; Bevacizumab |
| Core Tip |
Vascular endothelial growth factor (VEGF) inhibitor is one of the pharmacological options for treating corneal neovascularization (CoNV) - the second major cause of blindness. The present study conducted a systematic review and meta-analysis support the use of Bevacizumab in the treatment of CoNV. The results of our study supports that anti-VEGF agents are effective in reducing CoNV, best-corrected visual acuity, and graft rejection/failure rate. In addition, our study found evidence supporting the improvement of visual acuity which was not significant in the previous systematic review and meta-analysis. |
| Publish Date |
2023-10-25 08:49 |
| Citation |
Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i30/7337.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i30.7337 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
